WEBVTT 00:00:00.041 --> 00:00:00.917 Sabrina, welcome. 00:00:01.668 --> 00:00:05.338 In your view, what are going to be the key trends shaping the 00:00:05.338 --> 00:00:07.465 biopharmaceutical sector this year? 00:00:07.465 --> 00:00:08.091 Do you think? 00:00:08.800 --> 00:00:11.094 I think, number one, of course, GenAI 00:00:11.094 --> 00:00:12.012 is everywhere. 00:00:12.178 --> 00:00:12.387 Yeah. 00:00:12.387 --> 00:00:15.807 So we'll have, we will see how the industry research and 00:00:15.807 --> 00:00:17.684 development will be influenced. 00:00:18.393 --> 00:00:21.688 We do see on the supply chain side, quite some developments 00:00:21.688 --> 00:00:24.107 coming up on operations, on commercial side. 00:00:24.399 --> 00:00:28.236 I think every pharma industry is testing the waters and to seize 00:00:28.236 --> 00:00:30.655 how to create value with the technology. 00:00:30.780 --> 00:00:31.281 Number one. 00:00:31.865 --> 00:00:34.409 Number two, innovation, of course. 00:00:34.409 --> 00:00:37.746 Yeah, question will be, I mean we have seen the GLP-1s hitting 00:00:37.746 --> 00:00:38.329 the market. 00:00:38.329 --> 00:00:41.541 Yeah, Alzheimer's in Europe is a big question mark. 00:00:41.916 --> 00:00:44.044 EMA was quite skeptical in the beginning. 00:00:44.044 --> 00:00:46.087 Right now we got green light. 00:00:46.087 --> 00:00:48.423 So how will the market develop there for patients? 00:00:48.715 --> 00:00:51.384 And then we have new technologies coming to market 00:00:51.384 --> 00:00:51.885 like RLTs. 00:00:52.218 --> 00:00:54.846 And in Europe, every market is so different. 00:00:54.846 --> 00:00:55.055 Yeah. 00:00:55.055 --> 00:00:58.349 So you have different regulatory requirements for how you're 00:00:58.349 --> 00:01:01.352 setting up the clinical pathways, what you put in place 00:01:01.352 --> 00:01:02.312 on infrastructure. 00:01:02.562 --> 00:01:05.607 So I think there are many questions on the physician side 00:01:05.607 --> 00:01:08.568 at the moment and I think pharmaceutical industry does a 00:01:08.568 --> 00:01:10.528 great job in Europe to address them. 00:01:10.737 --> 00:01:13.823 What are you most excited about at the moment? 00:01:13.823 --> 00:01:15.450 You spoke about all those innovations. 00:01:15.867 --> 00:01:16.618 Anything there? 00:01:17.786 --> 00:01:20.622 I'm most excited about the performance of my clients. 00:01:21.706 --> 00:01:24.250 We have amazing European-headquartered 00:01:24.250 --> 00:01:28.546 pharmaceutical companies on the innovative side, but also on the 00:01:28.546 --> 00:01:31.424 generic side, on pharmaceutical wholesale. 00:01:31.716 --> 00:01:35.720 So I think the clients have realized that Europe is of 00:01:35.720 --> 00:01:40.308 course a big region, but all the markets have their individual 00:01:40.308 --> 00:01:44.771 kind of challenges, requirements, political environments. 00:01:44.896 --> 00:01:49.025 And if I see how my clients have, top of their mind, how to 00:01:49.025 --> 00:01:52.904 best serve the patients there, in light of all economic 00:01:52.904 --> 00:01:57.492 challenges, that I think we will see increasingly across European 00:01:57.492 --> 00:02:00.245 countries, that impresses me every day. 00:02:00.703 --> 00:02:03.873 What do you think industry leaders, though, need to keep in mind? 00:02:03.873 --> 00:02:05.291 What should be top priority? 00:02:07.043 --> 00:02:09.712 Look, industry leaders, of course, many of the large 00:02:09.712 --> 00:02:10.964 companies they're listed. 00:02:11.381 --> 00:02:15.969 So stock price and how the market is evolving is of course 00:02:15.969 --> 00:02:20.056 a question right now in a new economic environment. 00:02:20.056 --> 00:02:24.144 Also with more pressure on budgets, more pressure on price. 00:02:24.144 --> 00:02:28.273 Having on the US side, IRA coming into play, of course some 00:02:28.273 --> 00:02:31.192 of them will see pressure on P&L side. 00:02:31.609 --> 00:02:33.611 Many of them have already prepared. 00:02:34.487 --> 00:02:36.698 Question will be about growth I think. 00:02:36.739 --> 00:02:40.618 And if I look at the large players, they have amazing 00:02:40.618 --> 00:02:44.914 pipelines and really broad portfolios, but what will really 00:02:44.914 --> 00:02:47.083 drive growth in that industry? 00:02:47.792 --> 00:02:49.043 Thank you so much for your time. 00:02:49.502 --> 00:02:49.878 Thank you.